Living Kidney Donation
10
3
3
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (10)
Telemedicine to Support Living Kidney Donor Candidates
Long-Term Risk of Gout in Living Kidney Donors
Long-term Risk of Cardiovascular Disease in Living Kidney Donors
Assessment of Risks of Perinephric Fat Thickness to Adverse Renal Outcomes Post Donor Nephrectomy
Fracture Risk in Living Kidney Donors
Preoperative Psychotherapy and Its Effects on Anxiety, Hemodynamics, and Pain in Living Kidney Donors
Hydrocelectomies in Male Donors
The Living Kidney Donor Safety Study
Vascular Remodeling After Living Kidney Donation Study
eHealth Usability in Living Kidney Donation